NCT04368936

Brief Summary

Febrile seizures (FS) are the most common neurological disorder in chilhood. The etiology of FN is still the subject of numerous studies and it is known that it can depend on genetic predisposition.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
121

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2015

Longer than P75 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 31, 2015

Completed
4.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 15, 2019

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

April 24, 2020

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 30, 2020

Completed
1.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2021

Completed
Last Updated

October 19, 2021

Status Verified

October 1, 2021

Enrollment Period

4.1 years

First QC Date

April 24, 2020

Last Update Submit

October 10, 2021

Conditions

Keywords

gene polymorphismsfebrile seizureKCC2 geneTRPV1 gene

Outcome Measures

Primary Outcomes (2)

  • Detection of the polymorphism in the TRPV1 gene polymorphisms

    The detection of the polymorphism in the TRPV1 gene will be done by the PCR Real time method: During PCR ampification, in addition to primers, an allele of specific oligonucleotide probes is used, which at the 5 'end is labeled with specific fluorescent dye (Reporter dye, eg VIC and FAM), while at the 3' position there is a quencher, which is the role of blocking fluorescence emissions.The fluorescence intensity increases during each cycle and allows us to monitor dynamic reactions in real time.After the final PCR reaction, increasing the fluorescence of the dyes is displayed on the heterozygosity of the test allele. Fluorescence coupling of only one color indicates a homozygous state.VIC dye corresponds to allele C, and FAM dye to allele G.

    2 weeks

  • Detection of the polymorphism in the KCC2 gene polymorphisms

    The detection of the polymorphism in the KCC2 gene will be done by the PCR Real time method: During PCR ampification, in addition to primers, an allele of specific oligonucleotide probes is used, which at the 5 'end is labeled with specific fluorescent dye (Reporter dye, eg VIC and FAM), while at the 3' position there is a quencher, which is the role of blocking fluorescence emissions.The fluorescence intensity increases during each cycle and allows us to monitor dynamic reactions in real time.After the final PCR reaction, increasing the fluorescence of the dyes is displayed on the heterozygosity of the test allele. Fluorescence coupling of only one color indicates a homozygous state. VIC dye corresponds to allele C, and FAM dye to allele T.

    2 weeks

Study Arms (6)

FS: Febrile Seizures

Involved patient with diagnosed Febrile Seizures which were hospitalized or recieved ambulatory treatment in University Children´s Hospital in Belgrade. Ages 1-14 years

Genetic: Isolated DNA, Real Time PCR

CN: Control group

The control group was made of healthy children older than 5 years of age, which have never had any neurological disorders in their anamnesis and who were patients in preschool or school dispensaries in the city of Belgrade

Genetic: Isolated DNA, Real Time PCR

SFS : group of individuals with simple FS

Simplex febrile seizures (SFS) last shorter than 15 minutes and their type is tonic-clonic. Also, they did not show signs of recidivism during the first 24 hours and were diagnosed at the patients aged from 6th months to 5th year

Genetic: Isolated DNA, Real Time PCR

CFS : group of individuals with complex FS

Complex febrile seizures (CFS) were diagnosed at those patients that had focal seizure or epileptic status or seizure having the body temperature lower than 38 degree, which occurred outside of the typical age group and finally which repeated in the first 24 hours again

Genetic: Isolated DNA, Real Time PCR

WFS: group of individuals with FS and without epilepsia

group of children with Febrile Seizure and not developed Epilepsia

Genetic: Isolated DNA, Real Time PCR

EFS: group of individuals with Epilepsia and Febrile Seizures

Group of children with Febrile Seizures, who have developed Epilepsy

Genetic: Isolated DNA, Real Time PCR

Interventions

We are isolated DNA from the blood sample. To determine the genotypes of the analyzed polymorphisms use real-time PCR using TaqMan essays. When analyzing the KCC2 polymorphisms, the VIC dye gene corresponded to the C allele, and the FAM dye corresponded to the T allele, while at the TRPV1 gene polymorphism, the VIC dye corresponded to the C allele and the FAM dye to the G allele.

CFS : group of individuals with complex FSCN: Control groupEFS: group of individuals with Epilepsia and Febrile SeizuresFS: Febrile SeizuresSFS : group of individuals with simple FSWFS: group of individuals with FS and without epilepsia

Eligibility Criteria

Age1 Year - 14 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodProbability Sample
Study Population

The Febrile Seizure affected children as well as the individuals from the control group were members of the same population (Serbian).

You may qualify if:

  • Our research involve patient with diagnosed Febrile Seizure which were hospitalized or recieved ambulatory treatment in University Children´s Hospital in Belgrade
  • For each patient, a diagnosis of FS was made based on the ILAE definition (International Leage

You may not qualify if:

  • Patients with evidence of intracranial infections and metabolic disbalance
  • Patients with incomplited medical documentation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (6)

  • Leung AK, Hon KL, Leung TN. Febrile seizures: an overview. Drugs Context. 2018 Jul 16;7:212536. doi: 10.7573/dic.212536. eCollection 2018.

    PMID: 30038660BACKGROUND
  • Dimitrijevic S, Cvjeticanin S, Pusica A, Jekic B, Filipovic T, Nikolic D. Anthropogenetic Variability in the Group of Individuals with Febrile Seizures: Population-Genetic Study. Biomed Res Int. 2018 Jul 5;2018:7845904. doi: 10.1155/2018/7845904. eCollection 2018.

    PMID: 30069480BACKGROUND
  • Reid AY, Riazi K, Campbell Teskey G, Pittman QJ. Increased excitability and molecular changes in adult rats after a febrile seizure. Epilepsia. 2013 Apr;54(4):e45-8. doi: 10.1111/epi.12061. Epub 2013 Jan 7.

    PMID: 23293960BACKGROUND
  • Puskarjov M, Seja P, Heron SE, Williams TC, Ahmad F, Iona X, Oliver KL, Grinton BE, Vutskits L, Scheffer IE, Petrou S, Blaesse P, Dibbens LM, Berkovic SF, Kaila K. A variant of KCC2 from patients with febrile seizures impairs neuronal Cl- extrusion and dendritic spine formation. EMBO Rep. 2014 Jun;15(6):723-9. doi: 10.1002/embr.201438749. Epub 2014 Mar 24.

    PMID: 24668262BACKGROUND
  • Huang WX, Yu F, Sanchez RM, Liu YQ, Min JW, Hu JJ, Bsoul NB, Han S, Yin J, Liu WH, He XH, Peng BW. TRPV1 promotes repetitive febrile seizures by pro-inflammatory cytokines in immature brain. Brain Behav Immun. 2015 Aug;48:68-77. doi: 10.1016/j.bbi.2015.01.017. Epub 2015 Mar 20.

    PMID: 25801060BACKGROUND
  • Xu H, Tian W, Fu Y, Oyama TT, Anderson S, Cohen DM. Functional effects of nonsynonymous polymorphisms in the human TRPV1 gene. Am J Physiol Renal Physiol. 2007 Dec;293(6):F1865-76. doi: 10.1152/ajprenal.00347.2007. Epub 2007 Oct 3.

    PMID: 17913835BACKGROUND

Biospecimen

Retention: SAMPLES WITH DNA

* C\_16186074\_10 for rs2297201 polymorphisms KCC2 gene * C\_1093688\_20 za rs222747 polymorphisms TRPV1 gene (Thermo Fisher Scientific, Walthman, MA, SAD)

MeSH Terms

Conditions

Seizures, Febrile

Interventions

Real-Time Polymerase Chain Reaction

Condition Hierarchy (Ancestors)

SeizuresNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Polymerase Chain ReactionNucleic Acid Amplification TechniquesGenetic TechniquesInvestigative Techniques

Study Officials

  • Sanja Dimitrijevic, PhD

    Specila hospital for cerebral palsy and developmental neurology

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Target Duration
2 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 24, 2020

First Posted

April 30, 2020

Study Start

March 31, 2015

Primary Completion

May 15, 2019

Study Completion

August 1, 2021

Last Updated

October 19, 2021

Record last verified: 2021-10

Data Sharing

IPD Sharing
Will share

All of individual participant data collected during the trial, after deindetification.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR
Time Frame
Immediately after publication. No end date.
Access Criteria
Anyone who wishes to access the data.